Brief: Synact Pharma Q2 Pre-Tax Loss Narrows To SEK 7.3 Million
30/08/2019 08:17
Aug 30 (Reuters) - SynAct Pharma AB SYNACT.TE :
* Q2 LOSS AFTER FINANCIAL ITEMS SEK 7.3 MILLION VERSUS LOSS SEK 9.9 MILLION YEAR AGO
Source text for Eikon: ID:nNDL4D6n8C
Further company coverage: SYNACT.TE
(Gdynia Newsroom)
((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))
Recent news on SynAct Pharma AB
See all newsBrief: SynAct: Shareholding Board, Management Sign Lock-Up Agreements
Sweden's SynAct Pharma posts wider Q1 net loss as expenses rise
Brief: SynAct Pharma Q1 Sales SEK 0
Brief: SynAct Pharma Carries Out Directed Issue Of New Shares
Brief: Synact Pharma Appoints Ann Kristin Led As CFO Effective March 2026